Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants

Project: Research

Project Details

StatusFinished
Effective start/end date01/13/26 → 05/1/26

Funding

  • Pfizer Incorporated: $15,534.00